Skip to main content
SpringerLink
Log in

The Pharmacokinetics of Zileuton in Healthy Young and Elderly Volunteers

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

The effects of age and gender on the single and multiple dose pharmacokinetics of zileuton have been examined in a phase I nonblinded study. A total of 27 healthy volunteers were evaluable, 9 in the young group (age range 20 to 40 years; 5 males and 4 females) and 18 in the elderly group (range 65 to 81 years; 9 males and 9 females). A single oral dose of zileuton 600mg was given to all volunteers on day 1 of the study and at 6-hour intervals from days 3 to 7.

Analysis of variance showed slight but significant decreases in the mean apparent clearance of total and free drug in the healthy elderly population after a single zileuton dose, but no significant age-related differences after multiple 6-hourly doses. Similarly, zileuton peak and trough plasma concentrations, and values for half-life, volume of distribution and protein binding were not significantly affected by age after either a single dose or multiple administration. Moreover, gender effects on the pharmacokinetics were also absent after correction for bodyweight differences.

From the results of the present study, it is concluded that there is no pharmacokinetic basis for alteration of zileuton dosage schedules in elderly patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carter GW, Young PR, Albert DH, et al. 5-Lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther 1991; 256: 929–37

    PubMed  CAS  Google Scholar 

  2. Israel E, Dermarkarian R, Rosenberg M, et al. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med 1990; 323: 1740–4

    Article  PubMed  CAS  Google Scholar 

  3. Collawn C, Rubin P, Perez N, et al. Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis. Am J Gastroenterol 1992; 873: 342–6

    Google Scholar 

  4. Laursen L-S, Naesdal J, Bukhare K, et al. Selective 5-lipoxygenase inhibition in ulcerative colitis. Lancet 1990; 335: 683–5

    Article  PubMed  CAS  Google Scholar 

  5. Iber FL, Murphy PA, Connor ES. Age-related changes in the gastrointestinal system: effects on drug therapy. Drugs and Aging 1994; 5: 34–48

    Article  PubMed  CAS  Google Scholar 

  6. Woodhouse K. Drugs and the liver. Part III: aging of the liver and the metabolism of drugs. Biopharm Drug Dispos 1992; 13:311–20

    Article  PubMed  CAS  Google Scholar 

  7. Woodhouse KW, Wynne HA. Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly. Clin Pharmacokinet 1988; 15: 287–94

    Article  PubMed  CAS  Google Scholar 

  8. Vestal RE. Aging and determinants of drug clearance. Hepatology 1989; 9: 331–4

    Article  PubMed  CAS  Google Scholar 

  9. Wynne HA, Gondevenos J, Rawlins MD, et al. Hepatic drug clearance: the effect of age using indocyanine green as a model compound. Br J Clin Pharmacol 1990; 30: 634–7

    Article  PubMed  CAS  Google Scholar 

  10. Granneman GR, Braeckman RA, Erdman KA. Determination of a new 5-lipoxygenase inhibitor, zileuton, and its inactive N-dehydroxylated metabolite in plasma by high performance liquid chromatography. Clin Pharmacokinet 1995; 29 Suppl. 2: 1–8

    Article  PubMed  CAS  Google Scholar 

  11. Machinist JM, Kukulka MJ, Bopp BA. In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite. Clin Pharmacokinet 1995; 29 Suppl. 2: 34–41

    Article  PubMed  CAS  Google Scholar 

  12. Massoud N. Pharmacokinetic considerations in geriatric patients. In: Benet LZ, Massoud N, Gambertoglio JG, editors. Pharmacokinetic basis for drug treatment. New York: Raven Press, 1984:283–310

    Google Scholar 

  13. Crooks J, O’Malley S, Stevenson IH. Pharmacokinetics in the elderly. An update. Clin Pharmacokinet 1975; 1: 280–96

    Article  Google Scholar 

  14. Greenblatt DJ, Sellers EM, Shader RJ. Drug disposition in old age. N Engl J Med 1982; 18: 1081–8

    Google Scholar 

  15. Greenblatt DJ, Divoll M, Abernathy DR, et al. Benzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics. Drug Metab Rev 1983; 14: 251–92

    Article  PubMed  CAS  Google Scholar 

  16. Greenblatt DJ, Abernathy DR, Shader RI. Pharmacokinetic aspects of drug therapy in the elderly. Ther Drug Monitor 1986; 8: 249–55

    Article  CAS  Google Scholar 

  17. Greenblatt DJ, Shader RI, Harmatz JS. Implications of altered drug disposition in the elderly: studies of benzodiazapines. J Clin Pharm 1989; 29: 866–72

    CAS  Google Scholar 

  18. Rawlins MD, James OFW, Williams FM, et al. Age and the metabolism of drugs. Quarterly J Med 1987; 64: 545–7

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacokinetics and Biopharmaceutics Department, Abbott Laboratories D4PK, AP13A, 100 Abbott Park Road, Abbott Park, Illinois, 60064-3500, USA

    Rene A. Braeckman,  G. Richard Granneman & Walid M. Awni

  2. Statistics Department, Abbott Laboratories, Abbott Park, Illinois, USA

    Charles S. Locke

  3. Biotransformation Department, Abbott Laboratories, Abbott Park, Illinois, USA

    Joseph M. Machinist

  4. Clinical Pharmacology Department, Abbott Laboratories, Abbott Park, Illinois, USA

    John H. Cavanaugh

Authors
  1. Rene A. Braeckman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Richard Granneman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles S. Locke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joseph M. Machinist
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John H. Cavanaugh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Walid M. Awni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braeckman, R.A., Granneman, G.R., Locke, C.S. et al. The Pharmacokinetics of Zileuton in Healthy Young and Elderly Volunteers. Clin-Pharmacokinet 29 (Suppl 2), 42–48 (1995). https://doi.org/10.2165/00003088-199500292-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199500292-00007

Keywords

Search

Navigation